IndraLab

Statements

USP7 inhibits elaD. 1 / 1

| 1

reach

"By contrast, in pediatric cancer the majority of the USP7 mutations identified are loss-of-function mutations including frame shift mutations within the catalytic domain that would encode truncated USP7 proteins and missense mutations that have reduced deubiquitinase activity."

24710217

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP7 inhibits elaD. 1 / 1

INDRA sources:

Databases

Reading